Table 3 Postoperative data and outcomes
Variable | All Patients (n = 368) | Male (n = 242) | Female (n = 126) | p-value |
|---|---|---|---|---|
48 h-drainage loss (ml)* | 850 (500;1300) | 885 (500;1458) | 750 (350;1150) | 0.034 |
Postoperative blood transfusion | 247 (70.8%) | 166 (72.2%) | 81 (68.1%) | 0.424 |
Total number of packed red blood cells, unit | 3 (0–56) | 3.5 (0–56) | 2 (0–21) | 0.030 |
Total number of fresh frozen plasma, unit | 0 (0–76) | 0 (0–76) | 0 (0–25) | 0.027 |
Total number of platelets, unit | 0 (0–20) | 0 (0–20) | 0 (0–7) | 0.002 |
IABP/ECLS | 10 (2.8%) | 8 (3.4%) | 2 (1.7%) | 0.504 |
Reintubation | 66 (18.0%) | 51 (21.2%) | 15 (11.9%) | 0.028 |
Tracheotomy | 84 (22.9%) | 63 (26.1%) | 21 (16.7%) | 0.040 |
Postoperative delirium | 69 (18.9%) | 57 (23.8%) | 12 (9.5%) | 0.001 |
Postoperative myocardial infarction | 4 (1.1%) | 3 (1.3%) | 1 (0.8%) | 1.000 |
TIA / Stroke | 56 (15.3%) | 40 (16.7%) | 16 (12.7%) | 0.316 |
Electrical cardioversion | 26 (7.1%) | 14 (5.8%) | 12 (9.5%) | 0.192 |
CPR | 28 (7.7%) | 16 (6.7%) | 12 (9.5%) | 0.334 |
Bronchopulmonary infection | 48 (13.1%) | 38 (15.8%) | 10 (7.9%) | 0.033 |
Bacteriaemia/sepsis | 17 (4.6%) | 10 (4.2%) | 7 (5.6%) | 0.549 |
Rethoracotomy | 62 (16.9%) | 45 (18.7%) | 17 (13.5%) | 0.209 |
Sternal wound infection/VAC revision | 6 (1.6%) | 6 (2.5%) | 0 (0.0%) | 0.097 |
AKI KDIGO | 80 (22.0%) | 52 (21.8%) | 28 (22.6%) | 0.858 |
New–onset of Hemodialysis | 78 (21.4%) | 51 (21.2%) | 27 (21.8%) | 0.892 |
Temporary dialysis (d) | 4 (2;12) | 6 (3;13.5) | 3 (1;5) | 0.030 |
Atrial fibrillation | 40 (11.4%) | 26 (11.1%) | 14 (11.9%) | 0.833 |
Ventilation time (h) | 64 (21;188) | 63 (21;237) | 67 (19;145) | 0.270 |
ICU time (d) | 5 (2;11) | 5 (2;12) | 5 (2;9) | 0.442 |
Postoperative days | 11 (7;19) | 11.5 (8;20) | 9.5 (7;17) | 0.090 |
Hospital Mortality | 61 (17.0%) | 38 (16.2%) | 23 (18.4%) | 0.604 |
Cardiac death | 36 (56.3%) | 22 (55.0%) | 14 (58.3%) | – |
Cerebral death | 4 (6.3%) | 2 (5.0%) | 2 (8.3%) | – |
Sepsis | 3 (4.7%) | 3 (7.5%) | 0 (0.0%) | – |
MOF | 21 (32.8%) | 13 (32.5%) | 8 (33.3%) | – |
30 d-mortality | 64 (17.4%) | 40 (16.5%) | 24 (19.0%) | 0.545 |